Table 2:

Diagnostic indices of US diagnoses for Bethesda class III nodules

MeasureExclusion of Borderline US Diagnosis (%)Inclusion of Borderline US Diagnosis into Benign Category (%)Inclusion of Borderline US Diagnosis into Malignant Category (%)
Sensitivity14/14 (100)14/22 (63.6)22/22 (100)
Specificity18/19 (94.7)20/21 (95.2)18/21 (85.7)
PPV14/15 (93.3)14/15 (93.3)22/25 (88.0)
NPV18/18 (100)20/28 (71.4)18/18 (100)
Accuracy32/33 (97.0)34/43 (79.1)40/43 (93.0)
False-negative rate0/14 (0)8/22 (36.4)0/22 (0)
False-positive rate1/19 (5.3)1/21 (4.8)3/21 (14.3)
  • Note:—PPV indicates positive predictive value; NPV, negative predictive value.